ResearcherSecond Military Medical UniversityNo recent work listed
Chenyan Zhao
Matched on ORCID iD 0000-0002-1807-314X; OpenAlex author ID A5016157564. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper
Papers 5
- CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/2162402x.2016.1258504↗
- Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. First author DOI 10.3892/or.2013.2960↗
- Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2013.2420↗
- Surviving cells after treatment with gemcitabine or 5-fluorouracil for the study of de novo resistance of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2011.09.018↗
- Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses. First author DOI 10.3892/mmr.2012.1013↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jing Zhang · 4 shared papers, 2012–2014 · strength 0.15
- Paper Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2013.2960↗
- Paper Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2013.2420↗
- Paper Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses. DOI 10.3892/mmr.2012.1013↗
- Min Shi · 3 shared papers, 2013–2017 · strength 0.14
- Paper CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancr… DOI 10.1080/2162402x.2016.1258504↗
- Paper Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2013.2960↗
- Paper Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2013.2420↗
- Ming-hua Zhu · 3 shared papers, 2012–2014 · strength 0.11
- Paper Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2013.2960↗
- Paper Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2013.2420↗
- Paper Surviving cells after treatment with gemcitabine or 5-fluorouracil for the study of de novo resistance of pancreatic ca… DOI 10.1016/j.canlet.2011.09.018↗
- Qinghua Liu · 3 shared papers, 2012–2014 · strength 0.11
- Paper Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2013.2960↗
- Paper Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2013.2420↗
- Paper Surviving cells after treatment with gemcitabine or 5-fluorouracil for the study of de novo resistance of pancreatic ca… DOI 10.1016/j.canlet.2011.09.018↗
- Minghua Zhu · 2 shared papers, 2012–2017 · strength 0.10
- Paper CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancr… DOI 10.1080/2162402x.2016.1258504↗
- Paper Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses. DOI 10.3892/mmr.2012.1013↗
- Shu‐Hui Zhang · 2 shared papers, 2013–2014 · strength 0.08
- Xiongfei Xu · 1 shared paper, 2017 · strength 0.06
- Gang Y Jin · 1 shared paper, 2017 · strength 0.06
- Biao Yang · 1 shared paper, 2017 · strength 0.06
- Jing Zhang · 1 shared paper, 2017 · strength 0.06
- Ying Chen · 1 shared paper, 2017 · strength 0.06
- Shiwei Guo · 1 shared paper, 2017 · strength 0.06
- Guiling Ding · 1 shared paper, 2017 · strength 0.06
- Yan Gu · 1 shared paper, 2017 · strength 0.06
- Ying Chen · 1 shared paper, 2013 · strength 0.04
- Qinghua Liu · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.